The Extreme Ends of the Treatment Response Spectrum to Botulinum Toxin in Cervical Dystonia.
Sara SamadzadehRaphaela BraunsHarald HefterPublished in: Toxins (2020)
These five patients indicate that the response of a patient to a BoNT preparation may be unexpected. Therefore, cautious onset of BoNT therapy is recommended as well as consequent dose adjustment later on and even switch to another BoNT/A preparation when a patient has already developed NABs against BoNT/A.